Pulmonary Hypertension

Review covers diagnosis, screening, prognosis, and highlights that treatment is generally divided into “background” therapy and specific drugs that target 3 molecular pathways, the choice of which, and decision to use combinations, driven largely by severity of illness and risk.

Source:

Annals of Internal Medicine